Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. WALDMANN TA; GOLDMAN CK; TOP L; GANSOW O; KASTENSPORTES C; ROESSLER E; ZAKNOEN S; WHITE J; HORAK I; CARRASQUILLO JA; REYNOLDS JC; NELSON DL
   THE TREATMENT OF HTLV-I-ASSOCIATED ADULT T-CELL LEUKEMIA (ATL) WITH GENETICALLY ENGINEERED MONOCLONAL-ANTIBODIES ARMED WITH RADIONUCLIDES
   Journal of acquired immune deficiency syndromes
   
   T.A. Waldmann et al., "THE TREATMENT OF HTLV-I-ASSOCIATED ADULT T-CELL LEUKEMIA (ATL) WITH GENETICALLY ENGINEERED MONOCLONAL-ANTIBODIES ARMED WITH RADIONUCLIDES", Journal of acquired immune deficiency syndromes, 6(6), 1993, pp. 671-671
2. WALDMANN TA; WHITE JD; GOLDMAN CK; TOP L; GRANT A; BAMFORD R; ROESSLER E; HORAK ID; ZAKNOEN S; KASTENSPORTES C; ENGLAND R; HORAK E; MISHRA B; DIPRE M; HALE P; FLEISHER TA; JUNGHANS RP; JAFFE ES; NELSON DL
   THE INTERLEUKIN-2 RECEPTOR - A TARGET FOR MONOCLONAL-ANTIBODY TREATMENT OF HUMAN T-CELL LYMPHOTROPHIC VIRUS-I-INDUCED ADULT T-CELL LEUKEMIA
   Blood
   
   T.A. Waldmann et al., "THE INTERLEUKIN-2 RECEPTOR - A TARGET FOR MONOCLONAL-ANTIBODY TREATMENT OF HUMAN T-CELL LYMPHOTROPHIC VIRUS-I-INDUCED ADULT T-CELL LEUKEMIA", Blood, 82(6), 1993, pp. 1701-1712